drugset / Trial / NCT04907825
A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF
Phase 4
Completed
14 enrolled
Cedars-Sinai Medical Center
National Institute on Aging (NIA) · collab
NaSingle-groupOpen-labelPrevention
Summary
This is a prospective, single-arm, feasibility pilot study of 20 participants (aged 60 years or older, with additional stroke risk factors and 'actionable' undertreated AF) recruited from a total of 4 retail and outpatient community pharmacies. Eligible participants will be enrolled in a 3-month active intervention of pharmacist-led OAC management. Participants will be passively followed for an additional 9 months to determine safety endpoints.
Timeline
- Start
- 2023-03-13
- Primary completion
- 2025-08-31
- Completion
- 2026-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Warfarin | Small molecule | — | Oral |